| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |